This page lists all pharmaceutical reports related to the field of Cancer Immunotherapy. The reports include market research reports and pipeline analyses.
- The Emerging Cancer Vaccine Market
- Cancer Stem Cells: Emerging Therapeutic, Diagnostics and Market Opportunities
- Drug Delivery in Cancer - technologies, markets and companies
- Cell Therapy - Technologies, Markets and Companies
- Cancer Diagnostic Testing World Markets
- Cancer Therapeutics Markets
- Stem Cell Markets
- Therapeutic Monoclonal Antibodies, 2006-2011
- World market for cancer vaccines 2007-2012
- Pipeline Insight: Hematological Malignancies - Pursuit for the next blockbuster intensifies
- Early Toxicology: Markets and Approaches
- Melanoma - Lucrative commercial opportunities persist
- Therapeutic Cancer Vaccines - A turbulent path from bench to bedside
- Gynecological Cancers - Niche opportunities in advanced disease
- Non-Small Cell Lung Cancer
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Colorectal Cancer - Shaping the future dynamics of colorectal cancer management
- Molecular Targeted Cancer Therapies - More drugs on the market, more targets in the pipeline
- Supportive Care in Cancer Treatment - Some first-generation products proving difficult to dislodge
- Pipeline Insight: Breast Cancer - A diverse and increasingly crowded pipeline
- Pipeline Insight: Cancer Overview Emerging Therapeutic and Commercial Opportunities
- From Blockbuster to Nichebuster
- Commercial Insight Top 20 Cancer Therapeutics
- Ovarian Cancer: Growing importance as secondary indication for targeted therapies
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Cancer Therapeutics 2006
- Biogenerics
- Cancer Vaccines Measuring Market Potential
- Acute Leukemias - Persistent unmet needs confer significant commercial opportunity
- Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
- Preclinical Cancer Therapeutics 2007
- Chemotherapy Market Insights, 2006-2016
- Renal Cell Carcinoma - Novel Targeted Treatments to Fill the Void
- Therapeutic Vaccines
- Biogenerics 2005: A New Level of Complexity
- Myelodysplastic Syndrome - An underserved population offers commercial opportunity
- Stakeholder Insight: Prostate Cancer
- Chronic Leukemias - Curative Intent Raises the Bar
- Innovative Targeted Oncology Therapies
- Optimizing Targeted Treatment in Cancer: Negotiating the Challenges to Success
- Pipeline Insight: Hematological malignancies - Targeted treatments & immunotherapy
- Monoclonal Antibody Therapies: Evolving into a $30 billion market
- Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer
- Pipeline Insight: Cancer Vaccines and Cell Therapies
- Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
- Cancer Biomarkers: Enhancing diagnostic, therapeutic and developmental strategies
- Non-Small Cell Lung Cancer - Angiogenesis and signal transduction inhibitors to expand market
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Hepatocellular Carcinoma - Opportune indication for novel therapies
- Supportive Care in Oncology-Significant growth opportunities in new supportive care indications
- Drug Discovery Tools for High-Content Analysis
- Personalized Medicine
- Colorectal Cancer Drug Pipeline Update 2007
- Stakeholder Opinions: Primary Brain Cancer
- Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted therapies
- Melanoma Therapeutics: Which Strategy Will Take Us There?
- Apoptosis: Promise or deception?
- Breast Cancer Drug Pipeline Update 2007
- Breast Cancer - Therapeutic And Competitive Insights
- Cancer Vaccines Fantasy or Future?
- Immunotherapy in Oncology: Gaining Momentum
- MYELODYSPLASTIC SYNDROME - Therapy Area Pipeline Report
- LEUKEMIA - Therapy Area Pipeline Report
- BREAST CANCER - Therapy Area Pipeline Report
- GASTRIC CANCER - Therapy Area Pipeline Report
- HEAD AND NECK CANCER - Therapy Area Pipeline Report
- KIDNEY CANCER - Therapy Area Pipeline Report
- LIVER CANCER - Therapy Area Pipeline Report
- MELANOMA and SKIN CANCER - Therapy Area Pipeline Report
- MULTIPLE MYELOMA - Therapy Area Pipeline Report
- NON - HODGKIN LYMPHOMA (NHL) - Therapy Area Pipeline Report
- OVARIAN CANCER - Therapy Area Pipeline Report
- PANCREATIC CANCER - Therapy Area Pipeline Report
- PROSTATE CANCER - Therapy Area Pipeline Report
- Innovative and Targeted Cancer Therapies: Key technologies, new applications and leading players
- Decoding Big Pharmas R&D Strategy in Oncology
- Monoclonal Antibodies: strategic analysis of the mAb market out to 2012
- Pipeline Insight: Cancer Overview - Increasing diversity offers both high risk and reward
- The Future of Biosimilars: Key opportunities & emerging therapies
- Biomarker Technology Platforms for Cancer Diagnoses and Therapies
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Pipeline Insight: Molecular Targeted Cancer Therapies
- Stakeholder Insight: Renal Cancer - Targeted therapies rapidly take hold of market
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Immunomodulators: Therapeutic Needs, Pipelines and Prospects
- Translational Medicine in Biopharmaceutical Research and Development
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Pediatric Drugs - the Worldwide Market
- BAFF (BLys) and APRIL: Emerging Targets for autoimmune disease & Cancer Therapeutics
- Stakeholder Opinions: Malignant Melanoma - High Hurdles, High Rewards, Are Vaccines Only Skin Deep?
- The Future of Monoclonal Antibody Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011
- The World Market for Vaccines
- The Emerging Cancer Vaccine Market
- Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets
- Immunomodulators in Cancer Therapy: Emerging Products and Markets
- Gene Expression Profiling Markets
- Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market
- Myelodysplastic Syndromes - First approvals spur interest in niche market
- Non-Hodgkin's Lymphoma - Is there room to emulate Rituxan's success?
- Multiple Myeloma - Exploring new targets for multiple drug therapy
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Prostate Cancer - Hormone-refractory patients still waiting for treatment breakthroughs
- Head and Neck Cancer
- How to Conduct Clinical Trials in China
- The Cancer Market Outlook to 2012
- Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
- Cancer Cell Therapy Markets
- Companion Diagnostics in Personalized Medicine and Cancer Therapy
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- The Worldwide Market for Cancer Diagnostics
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- Pipeline Insight: Non-Small Cell Lung Cancer - emerging therapies
- Pipeline Insight: Breast Cancer - Targeted Therapies, New Cytotoxics and Vaccines
